NASDAQ · Price History

Kardigan, Inc. (KARD) Stock Price History & Returns

$13.19 NASDAQ: KARD Market Cap $1.18B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Kardigan, Inc. (KARD) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $13.19 sits 6% of the way up a 52-week range of $12.23 to $27.00; 51.1% below the 52-week high; below its 50-day moving average of $14.98; below its 200-day average of $18.52; a beta of 6.05 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-40.1%

Monthly closing prices

The last 6 months, newest first. 0 of 5 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$13.19-6.7%
October 2026$14.13-4.2%
September 2026$14.75-26.8%
August 2026$20.16-3.2%
July 2026$20.82-12.7%
June 2026$23.85—

Kardigan, Inc. (KARD) price history — frequently asked questions

How has Kardigan, Inc. performed over the last year?

Kardigan, Inc. (KARD) has risen 0.0% over the last twelve months, measured on price alone.

What is Kardigan, Inc.'s five-year return?

Over five years the KARD share price has gained 0.0%, excluding dividends.

What is Kardigan, Inc.'s 52-week range?

Over the last year Kardigan, Inc. (KARD) has traded between $12.23 and $27.00.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.